Abacavir 600 mg

DRUG2 trials

Sponsors

University of North Carolina, Chapel Hill, Fundacion Clinic per a la Recerca Biomédica

Conditions

Acute HIV InfectionHIVHIV-1-infectionSolid Organ Transplant

Phase 4

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

CompletedNCT03360682

Fundacion Clinic per a la Recerca BiomédicaHIV-1-infection, Solid Organ Transplant

Start: 2018-04-13End: 2020-05-21Updated: 2025-09-30

Unknown Phase

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection

CompletedNCT02384395

University of North Carolina, Chapel HillAcute HIV Infection, HIV

Start: 2015-09-30End: 2021-09-17Updated: 2021-11-22

Related Papers

Dolutegravir-based Antiretroviral Therapy in People With HIV With Solid Organ Transplantation: A Single-arm Pilot Clinical Trial (DTG-SOT)

Open Forum Infectious Diseases2025-03-122 citations